TE_164

Basic information Differential Expression Stage analysis Survival analysis Correlation analysis

TE family LTR8A
TE superfamily ERV1
TE class LTR
Gene ENSG00000238142
Class Chimeric
Coding Non-coding
Tumor-specific score 1.86
Counts of samples TCGA_tumor:190; TCGA_normal:7; GTEx:108
TSS chr1(-):16894004



Transcript isoforms

Transcript_ID Gene Class Coding ORF Position
teRNA_164.1 ENSG00000238142 Chimeric Non-coding Non-coding chr1(-):16888765,16888785,16889216,16889603,16893973,16894005
teRNA_164.2 ENSG00000238142 Chimeric Non-coding Non-coding chr1(-):16888762,16888782,16889216,16889603,16893973,16894005
teRNA_164.3 ENSG00000238142 Chimeric Non-coding Non-coding chr1(-):16888765,16888785,16888920,16889029,16889216,16889603,16893973,16894005
teRNA_164.4 ENSG00000238142 Chimeric Non-coding Non-coding chr1(-):16888765,16888785,16888920,16889603,16893973,16894005
teRNA_164.5 ENSG00000238142 Chimeric Non-coding Non-coding chr1(-):16888762,16888782,16888920,16889603,16893973,16894005


GTEx

The proportion of samples in which the TE-initiated transcript was expressed across 46 body sites in the Genotype-Tissue Expression (GTEx) project.




TCGA

The proportion of samples in which the TE-initiated transcript was expressed across 33 cancer types from The Cancer Genome Atlas (TCGA).




GTEx

The expression of TE-initiated transcript across 46 body sites from The Genotype-Tissue Expression (GTEx) project.




TCGA

The expression of TE-initiated transcript across 33 cancer types from The Cancer Genome Atlas (TCGA).